Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

FHI vs KKRT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

FHI Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 9–1 Matrix Metrics)

FHI Overall Winner 6-Pillar Tally: FHI 5 – 0 KKRT (1 Tie) Matrix Metrics: FHI 9 – 1 KKRT

As of Nov 17, 2026, Federated Hermes, Inc. (FHI) is the stronger overall head-to-head candidate over KKR & Co. Inc. 6.875% Subordinated Notes due 2065 (KKRT) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). FHI carries a Unified Composite Score of 49.8/100 (HOLD) at $61.33 (10.5x Forward P/E, 27.8% operating margin), whereas KKRT carries 43.2/100 (HOLD) at $22.43 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: FHI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 51.4); meanwhile KKRT is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About FHI vs KKRT
FHI NYSE Head-to-Head Winner
Federated Hermes, Inc.
Investment Advice
$61.33
-2.33% 1D
Market Cap $4.7B
TTM Revenue $1.97B
Forward P/E 10.5x
Beta / 30D Vol 0.57β · 38% Vol
Unified Composite Score
49.8 / 100 HOLD
Tech 42.0 Fund 47.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 51
RSI-14: 51.4 · SMA20: $61.10 · SMA50: $58.67
KKRT NYSE
KKR & Co. Inc. 6.875% Subordinated Notes due 2065
Investment Advice
$22.43
+1.68% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.26β · 16% Vol
Unified Composite Score
43.2 / 100 HOLD
Tech 46.0 Fund 45.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -0.9%) with fading momentum, RSI 47
RSI-14: 47.0 · SMA20: $22.62 · SMA50: $22.77

6-Pillar Scorecard Institutional Category Breakdown (FHI 5 – 0 KKRT)

Columns: Metric · FHI · KKRT
1. Valuation Multiples FHI
Forward P/E 10.5x N/M
Trailing P/E 11.5x N/M
PEG Ratio 1.50x N/M
EV / Revenue 2.4x N/M
2. Growth & Scale FHI
Revenue Growth (YoY) +8.1% N/A
Earnings Growth (YoY) +11.9% N/A
TTM Revenue (USD) $1.97B N/A
Market Cap $4.7B N/A
3. Profitability & Quality FHI
Gross Margin 69.3% N/A
Operating Margin 27.8% N/A
Net Profit Margin 21.3% N/A
Return on Equity (ROE) 31.0% N/A
4. Balance Sheet & Cash Flow FHI
Cash Generation (TTM) $574M EBITDA N/A
Cash Flow Margin 29.1% EBITDA Mgn N/A
Net Cash / Leverage $18.32 Book/Sh · 31.0% ROE N/A ROE
Dividend Yield 2.27% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 22.1% (3rd %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Distribution
6. R&D & Supply-Chain Moat FHI
OpEx & R&D Intensity 41.5% of Rev ($818M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Asset Management Operator Investment Advice Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: FHI (9) vs KKRT (1)
Institutional Metric FHI KKRT Criterion Row Edge
Market Capitalization
Scale
$4.7B N/A Larger Scale FHI
Trailing P/E Ratio
Valuation
11.5x N/M Lower Multiple FHI
Forward P/E Ratio
Valuation
10.5x N/M Lower Multiple FHI
Revenue Growth (YoY)
Growth
+8.1% N/A Higher Growth FHI
Operating Margin (TTM)
Profitability
27.8% N/A Higher Margin FHI
Net Profit Margin
Profitability
21.3% N/A Higher Margin FHI
Return on Equity (ROE)
Capital Efficiency
31.0% N/A Higher ROE FHI
52-Week Range Position
Momentum
70% ($47–$67) 18% ($22–$26) Stronger Trend FHI
Beta / 30D Volatility
Risk Regime
0.57β · 38% Vol 0.26β · 16% Vol Lower Realized Risk KKRT
Unified Institutional Score
Composite Signal
49.8 / 100 (HOLD) 43.2 / 100 (HOLD) Higher Composite FHI
Trailing 12M Revenue (USD)
Operating Scale
$1.97B N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
69.3% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.50x PEG · 2.4x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$574M EBITDA ($18.32 Book/Sh · 31.0% ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon FHI +11.71 pp
FHI: +11.0% · KKRT: -0.71%
3M Horizon KKRT +1.97 pp
FHI: -4.15% · KKRT: -2.18%
6M Horizon FHI +22.46 pp
FHI: +14.16% · KKRT: -8.3%
1Y Horizon FHI +37.64 pp
FHI: +24.75% · KKRT: -12.89%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FHI vs KKRT. Trailing 12-month operating profitability (FHI 27.8% vs KKRT N/A) and valuation multiples (FHI 10.5x vs KKRT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

FHI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.97B
Gross Margin69.3%
Op. Margin27.8%
ROE / Fwd P/E31.0% · 10.5x
KKRT ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
FHI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 22.1%
IV Percentile 3rd %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact FHI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
KKRT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KKRT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
FHI Moat Profile Scale & Operating Efficiency Moat
Asset Management Operator
Competes within the Asset Management value chain with $4.7B market capitalization and 27.8% operating margin.
OpEx & R&D Reinvestment 41.5% of Rev ($818M)
90D Engineering Disclosures 0 Published
KKRT Moat Profile Cyclical / Execution-Driven Positioning
Investment Advice Operator
Competes within the Investment Advice value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ FHI vs KKRT Key Questions & Quantitative Answers

As of Nov 17, 2026, Federated Hermes, Inc. (FHI) is the stronger overall head-to-head candidate over KKR & Co. Inc. 6.875% Subordinated Notes due 2065 (KKRT) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). FHI carries a Unified Composite Score of 49.8/100 (HOLD) at $61.33 (10.5x Forward P/E, 27.8% operating margin), whereas KKRT carries 43.2/100 (HOLD) at $22.43 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: FHI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 51.4); meanwhile KKRT is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

FHI leads the Growth & Scale pillar: FHI posts +8.1% YoY revenue growth and +11.9% YoY earnings growth on $1.97B TTM revenue (69.3% gross margin, 27.8% operating margin), compared with KKRT at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, FHI generates $1.97B in USD-normalized revenue versus N/A for KKRT. In operating R&D and SG&A reinvestment, FHI deploys 41.5% of Rev ($818M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for KKRT.

FHI screens cheaper on headline valuation multiples. FHI trades at 10.5x Forward P/E, 11.5x Trailing P/E, 1.50x PEG, and 2.4x EV/Revenue (29.1% EBITDA margin), whereas KKRT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against FHI (31.0% ROE) versus KKRT (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, FHI carries 22.1% implied volatility (3rd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.57β · 38% Vol realized risk). By comparison, KKRT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.26β · 16% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.